Sen. Bernie Sanders (I-Vt.) said he has launched an investigation into Ozempic, a highly popular medication originally for diabetes and now used for obesity, which costs Americans over $900 before insurance but can be produced for less than $5 a month.
Alongside Wegovy, its sister drug, Ozempic has become a household name touted by celebrities from Elon Musk to Oprah Winfrey. Over the past year, demand for the drugs has exploded despite soaring costs and limited insurance coverage, transforming their maker, Copenhagen-based Novo Nordisk, into Europe’s most valuable company.
